In the context of obesity-related leptin-resistant conditions, an approach toward a partial leptin reduction state in the hypothalamus can restore the sensitivity of both insulin and leptin, a therapeutic intervention that directly or indirectly inhibits leptin levels and triggers significant weight loss along with metabolic homeostasis [121]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.